Biogaia

Biogaia Gross Margin

The Gross Margin of Biogaia (BIOG B.ST) as of Nov 11, 2026 is 73.37 %. In the previous year, Gross Margin was 72.45 % — a change of 1.27% (higher).

Gross Margin

73.37 %

YoY

1.27%

Last updated:

Gross Margin of Biogaia is 2025 73.37 % . Gross Margin of Biogaia was 2024 72.45 % . It decreases by 1.27% higher compared to the previous year.

For Biogaia, the gross margin of 73.4% is broadly stable versus 74.3% a few years ago.

The Biogaia Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
74.93 SEK
Jan 1, 2019
73.40 SEK
Jan 1, 2020
73.21 SEK
Jan 1, 2021
74.25 SEK
Jan 1, 2022
72.64 SEK
Jan 1, 2023
73.29 SEK
Jan 1, 2024
72.45 SEK
Jan 1, 2025
73.37 SEK
The Biogaia Gross Margin history
YEARGross MarginYoY
73.37 %+1.27%
72.45 %-1.15%
73.29 %+0.89%
72.64 %-2.17%
74.25 %+1.42%
73.21 %-0.27%
73.40 %-2.04%
74.93 %-0.54%
75.34 %+3.88%
72.53 %+4.13%
69.65 %-4.25%
72.74 %+10,628.61%
0.68 %-21.47%
0.86 %+25.75%
0.69 %+2.00%
0.67 %+1.22%
0.67 %-0.41%
0.67 %-0.40%
0.67 %-1.63%
0.68 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biogaia Stock analysis

What does Biogaia do? BioGaia AB generates revenue through its probiotic product segments, primarily featuring Limosilactobacillus reuteri strains. The Paediatrics segment sells drops, gut health tablets, oral rehydration solutions, and cultures for licensee products. The Adult Health segment offers gut health tablets, oral health lozenges, and cultures integrated into dairy products by licensees. The Other segment includes royalties from development projects and revenue from CapAble's packaging solutions. Products are marketed globally to consumers seeking health benefits from probiotics, with licensees distributing branded items under agreements. The company targets health-conscious consumers through direct sales and licensed partnerships. Paediatrics products focus on infant and child health, while Adult Health products address digestive and oral wellness. CapAble, a subsidiary, contributes through packaging solutions, and royalties from development projects provide additional income streams. All segments operate under BioGaia's brand, leveraging documented health benefits of their probiotic strains. Biogaia is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biogaia stock

Gross Margin of Biogaia is 73.37 % in 2025.

Gross Margin of Biogaia changed from 72.45 % to 73.37 %, representing a 1.27% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Biogaia since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Biogaia with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Biogaia

All Key Metrics — Biogaia